Bopindolol
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
ATC code | C07AA17 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | 69010-88-4 ![]() |
PubChem (CID) | 44112 |
DrugBank | DB08807 ![]() |
ChemSpider | 40146 ![]() |
UNII | KT304VZO57 ![]() |
KEGG | D07537 ![]() |
ChEMBL | CHEMBL357995 ![]() |
Chemical and physical data | |
Formula | C23H28N2O3 |
Molar mass | 380.48 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Bopindolol (INN) is a beta blocker. It is an ester which acts as a prodrug for its active metabolite 4-(3-t-butylamino-2-hydroxypropoxy)-2-methylindole.[1]
References[edit]
- ^ Nagatomo T, Hosohata Y, Ohnuki T, Nakamura T, Hattori K, Suzuki J, Ishiguro M (Spring 2001). "Bopindolol: pharmacological basis and clinical implications". Cardiovasc Drug Rev. 19 (1): 9–24. doi:10.1111/j.1527-3466.2001.tb00180.x. PMID 11314603.
![]() |
This article about an amine is a stub. You can help Wikipedia by expanding it. |
![]() |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |